share_log

Avenue Therapeutics | EFFECT: Others

SEC announcement ·  May 13 18:04
Summary by Futu AI
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC). The notice of effectiveness, which is a significant step for the company, was issued on May 10, 2024, at 4:00 PM. This form is typically used by companies to register securities for potential future offerings. The filing, under the file number 333-279125, indicates that Avenue Therapeutics has met the SEC's requirements to potentially offer securities to the public.
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC). The notice of effectiveness, which is a significant step for the company, was issued on May 10, 2024, at 4:00 PM. This form is typically used by companies to register securities for potential future offerings. The filing, under the file number 333-279125, indicates that Avenue Therapeutics has met the SEC's requirements to potentially offer securities to the public.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.